Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 14202 - tube, gastrointestinal - a flexible single/double lumen tube positioned in the stomach, duodenum, or jejunum for suction or enteral feeding.

Australia - English - Department of Health (Therapeutic Goods Administration)

regional health care group pty ltd - 14202 - tube, gastrointestinal - this tube is intended to be used to perform radiographic studies that show duodenal anatomy while eliminating the interference from peristaltic activity. the feeding tube is supplied with a torque cable to provide directional control into the duodenum once the patient has initially swallowed the feeding tube. this device is supplied sterile and is single use.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - abamectin; albendazole; naphthalophos - oral solution/suspension - abamectin anthelmintic active 1.0 g/l; albendazole carbamate-benzimidazole active 25.0 g/l; naphthalophos organophosphorus active 135.0 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - liver fluke - see label | lungworm - dictyocaulus viviparus | reduces output - viable worm/fluke eggs | roundworm - strongyloides papillosus | strains - resistant | tapeworm | benzimidazole | dipylidium caninum | gastrointestinal roundworm | large lungworm | levamisole | macrocyclic lactone | taenia hydatigena | taenia ovis | taenia pisiformis | taenia spp.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vet's best products pty ltd - pyrantel as pyrantel embonate; praziquantel; febantel - oral bolus, chewable - pyrantel as pyrantel embonate anthelmintic active 49.8 mg; praziquantel anthelmintic active 50.0 mg; febantel carbamate active 250.0 mg - parasiticides - dog | bitch | castrate | puppy - false hydatid tapeworm-taenia hydatigena | hookworm - ancylostoma braziliense | hookworm - ancylostoma caninum | hookworm - uncinaria stenocephala | hydatid tapeworm | roundworm - toxascaris leonina | roundworm - toxocara canis | sheep measles tapeworm - taenia ovis | tapeworm - dipylidium caninum | tapeworm - taenia pisiformis | tapeworm - taenia spp. | whipworm - trichuris vulpis | ascarid | human intestinal roundworm

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - imatinib - precursor cell lymphoblastic leukemia-lymphoma; gastrointestinal stromal tumors; dermatofibrosarcoma; myelodysplastic-myeloproliferative diseases; leukemia, myelogenous, chronic, bcr-abl positive; hypereosinophilic syndrome - antineoplastic agents - glivec is indicated for the treatment of , adult and paediatric patients with newly diagnosed philadelphia-chromosome (bcr-abl)-positive (ph+) chronic myeloid leukaemia (cml) for whom bone-marrow transplantation is not considered as the first line of treatment;, adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult and paediatric patients with newly diagnosed philadelphia-chromosome-positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic / myeloproliferative diseases (mds / mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and / or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfra rearrangement. , the effect of glivec on the outcome of bone-marrow transplantation has not been determined. glivec is indicated for: , the treatment of adult patients with kit (cd 117)-positive unresectable and / or metastatic malignant gastrointestinal stromal tumours (gist);, the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patients who have a low or very low risk of recurrence should not receive adjuvant treatment;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and / or metastatic dfsp who are not eligible for surgery. , in adult and paediatric patients, the effectiveness of glivec is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds / mpd, on haematological response rates in hes / cel and on objective response rates in adult patients with unresectable and / or metastatic gist and dfsp and on recurrence-free survival in adjuvant gist. the experience with glivec in patients with mds / mpd associated with pdgfr gene re-arrangements is very limited (see section 5.1). except in newly diagnosed chronic phase cml, there are no controlled trials demonstrating a clinical benefit or increased survival for these diseases.,

Australia - English - Department of Health (Therapeutic Goods Administration)

olympus australia pty ltd - 45712 - catheter, gastrointestinal balloon - a device intended for endoscopic dilation of strictures of the alimentary/digestive tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-practica pty ltd - 47168 - mineral-based gastrointestinal detoxifier - the device is used to strengthen the intestinal wall barrier.

Australia - English - Department of Health (Therapeutic Goods Administration)

fujifilm australia pty ltd - 45712 - catheter, gastrointestinal balloon - this product is a balloon for containing the ultrasonic transmitting medium to be used in combination with an ultrasonic endoscope in a medical facility under the supervision of a physician. this product is not intended to be used for children or infants.

Australia - English - Department of Health (Therapeutic Goods Administration)

fujifilm australia pty ltd - 45712 - catheter, gastrointestinal balloon - this is a balloon intended to be used in combination with endoscope, assists insertion of endoscope into the small intestine at a medical facility under the management of a physician. this product is not intended for use for any child or baby.

United States - English - NLM (National Library of Medicine)

hevert pharmaceuticals llc - bismuth subnitrate (unii: h19j064ba5) (bismuth cation - unii:zs9cd1i8ye), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), ipecac (unii: 62i3c8233l) (ipecac - unii:62i3c8233l), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919) - bismuth subnitrate 6 [hp_x] - for temporary relief of minor symptoms of gastrointestinal distress, such as: - pressure and pain in the upper abdomen - cramps in the upper abdomen - nausea and vomiting - flatulence and eructation - abdominal fullness these statements have not been evaluated by the food and drug administration. they are supported by traditional homeopathic principles.